nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Temozolomide—malignant glioma	0.358	1	CbGbCtD
Hydralazine—AOC3—endothelium—malignant glioma	0.0411	0.106	CbGeAlD
Hydralazine—AOC3—blood vessel—malignant glioma	0.0379	0.0979	CbGeAlD
Hydralazine—RYR2—brainstem—malignant glioma	0.0344	0.0889	CbGeAlD
Hydralazine—RYR2—telencephalon—malignant glioma	0.0306	0.0789	CbGeAlD
Hydralazine—RYR2—medulla oblongata—malignant glioma	0.024	0.062	CbGeAlD
Hydralazine—RYR2—midbrain—malignant glioma	0.022	0.0567	CbGeAlD
Hydralazine—AOC3—retina—malignant glioma	0.02	0.0516	CbGeAlD
Hydralazine—RYR2—central nervous system—malignant glioma	0.0174	0.0448	CbGeAlD
Hydralazine—RYR2—cerebellum—malignant glioma	0.017	0.0438	CbGeAlD
Hydralazine—P4HA1—telencephalon—malignant glioma	0.0147	0.038	CbGeAlD
Hydralazine—AOC3—medulla oblongata—malignant glioma	0.0145	0.0373	CbGeAlD
Hydralazine—RYR2—brain—malignant glioma	0.0138	0.0356	CbGeAlD
Hydralazine—AOC3—midbrain—malignant glioma	0.0132	0.0341	CbGeAlD
Hydralazine—P4HA1—medulla oblongata—malignant glioma	0.0116	0.0298	CbGeAlD
Hydralazine—P4HA1—midbrain—malignant glioma	0.0106	0.0273	CbGeAlD
Hydralazine—AOC3—central nervous system—malignant glioma	0.0105	0.027	CbGeAlD
Hydralazine—P4HA1—spinal cord—malignant glioma	0.0103	0.0266	CbGeAlD
Hydralazine—AOC3—cerebellum—malignant glioma	0.0102	0.0264	CbGeAlD
Hydralazine—P4HA1—central nervous system—malignant glioma	0.00836	0.0216	CbGeAlD
Hydralazine—AOC3—brain—malignant glioma	0.00831	0.0214	CbGeAlD
Hydralazine—P4HA1—cerebellum—malignant glioma	0.00817	0.0211	CbGeAlD
Hydralazine—Digestion impaired—Temozolomide—malignant glioma	0.00772	0.0442	CcSEcCtD
Hydralazine—P4HA1—brain—malignant glioma	0.00664	0.0171	CbGeAlD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ATP1B2—malignant glioma	0.00573	0.0715	CbGpPWpGaD
Hydralazine—Leukocytosis—Carmustine—malignant glioma	0.00568	0.0325	CcSEcCtD
Hydralazine—RYR2—Ion channel transport—ATP1B2—malignant glioma	0.00536	0.0669	CbGpPWpGaD
Hydralazine—Vascular purpura—Temozolomide—malignant glioma	0.00419	0.024	CcSEcCtD
Hydralazine—Nasal congestion—Temozolomide—malignant glioma	0.00411	0.0235	CcSEcCtD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—malignant glioma	0.00391	0.0489	CbGpPWpGaD
Hydralazine—Purpura—Temozolomide—malignant glioma	0.00389	0.0222	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00378	0.0472	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00349	0.0436	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00337	0.0421	CbGpPWpGaD
Hydralazine—Pancytopenia—Carmustine—malignant glioma	0.00318	0.0182	CcSEcCtD
Hydralazine—Neutropenia—Carmustine—malignant glioma	0.00313	0.0179	CcSEcCtD
Hydralazine—Pancytopenia—Temozolomide—malignant glioma	0.00307	0.0176	CcSEcCtD
Hydralazine—Dysuria—Temozolomide—malignant glioma	0.00303	0.0173	CcSEcCtD
Hydralazine—Neutropenia—Temozolomide—malignant glioma	0.00303	0.0173	CcSEcCtD
Hydralazine—Depression—Carmustine—malignant glioma	0.00298	0.017	CcSEcCtD
Hydralazine—Weight decreased—Temozolomide—malignant glioma	0.00293	0.0168	CcSEcCtD
Hydralazine—Neuropathy peripheral—Carmustine—malignant glioma	0.00293	0.0167	CcSEcCtD
Hydralazine—Depression—Temozolomide—malignant glioma	0.00288	0.0165	CcSEcCtD
Hydralazine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00283	0.0162	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—YWHAE—malignant glioma	0.00272	0.034	CbGpPWpGaD
Hydralazine—Hallucination—Carmustine—malignant glioma	0.00267	0.0153	CcSEcCtD
Hydralazine—Hypoaesthesia—Carmustine—malignant glioma	0.00267	0.0153	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—YWHAE—malignant glioma	0.00264	0.0329	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00262	0.0327	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00262	0.0327	CbGpPWpGaD
Hydralazine—Hepatitis—Temozolomide—malignant glioma	0.00259	0.0148	CcSEcCtD
Hydralazine—Hypoaesthesia—Temozolomide—malignant glioma	0.00258	0.0147	CcSEcCtD
Hydralazine—Hallucination—Temozolomide—malignant glioma	0.00258	0.0147	CcSEcCtD
Hydralazine—Flushing—Carmustine—malignant glioma	0.00249	0.0142	CcSEcCtD
Hydralazine—Flushing—Temozolomide—malignant glioma	0.00241	0.0138	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00233	0.0291	CbGpPWpGaD
Hydralazine—Chills—Temozolomide—malignant glioma	0.00233	0.0133	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GJA1—malignant glioma	0.00224	0.0279	CbGpPWpGaD
Hydralazine—CYP3A4—central nervous system—malignant glioma	0.00222	0.00572	CbGeAlD
Hydralazine—Tremor—Carmustine—malignant glioma	0.00219	0.0125	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GJA1—malignant glioma	0.00217	0.027	CbGpPWpGaD
Hydralazine—Anaemia—Carmustine—malignant glioma	0.00216	0.0123	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00216	0.0269	CbGpPWpGaD
Hydralazine—Agitation—Carmustine—malignant glioma	0.00215	0.0123	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00213	0.0266	CbGpPWpGaD
Hydralazine—Tremor—Temozolomide—malignant glioma	0.00211	0.0121	CcSEcCtD
Hydralazine—Ill-defined disorder—Temozolomide—malignant glioma	0.00209	0.012	CcSEcCtD
Hydralazine—Leukopenia—Carmustine—malignant glioma	0.00209	0.012	CcSEcCtD
Hydralazine—Anaemia—Temozolomide—malignant glioma	0.00209	0.0119	CcSEcCtD
Hydralazine—Agitation—Temozolomide—malignant glioma	0.00207	0.0119	CcSEcCtD
Hydralazine—Malaise—Temozolomide—malignant glioma	0.00203	0.0116	CcSEcCtD
Hydralazine—Leukopenia—Temozolomide—malignant glioma	0.00202	0.0116	CcSEcCtD
Hydralazine—Palpitations—Temozolomide—malignant glioma	0.00199	0.0114	CcSEcCtD
Hydralazine—Myalgia—Carmustine—malignant glioma	0.00199	0.0114	CcSEcCtD
Hydralazine—Anxiety—Carmustine—malignant glioma	0.00198	0.0113	CcSEcCtD
Hydralazine—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00192	0.024	CbGpPWpGaD
Hydralazine—Arthralgia—Temozolomide—malignant glioma	0.00192	0.011	CcSEcCtD
Hydralazine—Myalgia—Temozolomide—malignant glioma	0.00192	0.011	CcSEcCtD
Hydralazine—Anxiety—Temozolomide—malignant glioma	0.00191	0.0109	CcSEcCtD
Hydralazine—Oedema—Carmustine—malignant glioma	0.00191	0.0109	CcSEcCtD
Hydralazine—Discomfort—Temozolomide—malignant glioma	0.0019	0.0109	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00188	0.0235	CbGpPWpGaD
Hydralazine—Thrombocytopenia—Carmustine—malignant glioma	0.00187	0.0107	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00186	0.0233	CbGpPWpGaD
Hydralazine—Tachycardia—Carmustine—malignant glioma	0.00186	0.0106	CcSEcCtD
Hydralazine—Oedema—Temozolomide—malignant glioma	0.00184	0.0105	CcSEcCtD
Hydralazine—Anorexia—Carmustine—malignant glioma	0.00182	0.0104	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00181	0.0226	CbGpPWpGaD
Hydralazine—Thrombocytopenia—Temozolomide—malignant glioma	0.0018	0.0103	CcSEcCtD
Hydralazine—Hypotension—Carmustine—malignant glioma	0.00178	0.0102	CcSEcCtD
Hydralazine—Anorexia—Temozolomide—malignant glioma	0.00176	0.01	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00174	0.00993	CcSEcCtD
Hydralazine—Paraesthesia—Carmustine—malignant glioma	0.00171	0.00979	CcSEcCtD
Hydralazine—Dyspnoea—Carmustine—malignant glioma	0.0017	0.00972	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00168	0.00959	CcSEcCtD
Hydralazine—Decreased appetite—Carmustine—malignant glioma	0.00166	0.00947	CcSEcCtD
Hydralazine—Paraesthesia—Temozolomide—malignant glioma	0.00165	0.00946	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00164	0.00941	CcSEcCtD
Hydralazine—Dyspnoea—Temozolomide—malignant glioma	0.00164	0.00939	CcSEcCtD
Hydralazine—Constipation—Carmustine—malignant glioma	0.00163	0.00932	CcSEcCtD
Hydralazine—Dyspepsia—Temozolomide—malignant glioma	0.00162	0.00927	CcSEcCtD
Hydralazine—RYR2—Stimuli-sensing channels—RAF1—malignant glioma	0.00162	0.0202	CbGpPWpGaD
Hydralazine—Decreased appetite—Temozolomide—malignant glioma	0.0016	0.00915	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00159	0.00909	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00158	0.0197	CbGpPWpGaD
Hydralazine—Constipation—Temozolomide—malignant glioma	0.00157	0.00901	CcSEcCtD
Hydralazine—Feeling abnormal—Carmustine—malignant glioma	0.00157	0.00898	CcSEcCtD
Hydralazine—Feeling abnormal—Temozolomide—malignant glioma	0.00152	0.00868	CcSEcCtD
Hydralazine—Body temperature increased—Carmustine—malignant glioma	0.00151	0.00861	CcSEcCtD
Hydralazine—Urticaria—Temozolomide—malignant glioma	0.00146	0.00837	CcSEcCtD
Hydralazine—Body temperature increased—Temozolomide—malignant glioma	0.00146	0.00833	CcSEcCtD
Hydralazine—Hypersensitivity—Carmustine—malignant glioma	0.0014	0.00803	CcSEcCtD
Hydralazine—Hypersensitivity—Temozolomide—malignant glioma	0.00136	0.00776	CcSEcCtD
Hydralazine—Diarrhoea—Carmustine—malignant glioma	0.0013	0.00746	CcSEcCtD
Hydralazine—Pruritus—Temozolomide—malignant glioma	0.0013	0.00745	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.0013	0.0163	CbGpPWpGaD
Hydralazine—Dizziness—Carmustine—malignant glioma	0.00126	0.00721	CcSEcCtD
Hydralazine—Diarrhoea—Temozolomide—malignant glioma	0.00126	0.00721	CcSEcCtD
Hydralazine—Dizziness—Temozolomide—malignant glioma	0.00122	0.00696	CcSEcCtD
Hydralazine—Vomiting—Carmustine—malignant glioma	0.00121	0.00693	CcSEcCtD
Hydralazine—Rash—Carmustine—malignant glioma	0.0012	0.00687	CcSEcCtD
Hydralazine—Dermatitis—Carmustine—malignant glioma	0.0012	0.00686	CcSEcCtD
Hydralazine—Headache—Carmustine—malignant glioma	0.00119	0.00683	CcSEcCtD
Hydralazine—Vomiting—Temozolomide—malignant glioma	0.00117	0.0067	CcSEcCtD
Hydralazine—Rash—Temozolomide—malignant glioma	0.00116	0.00664	CcSEcCtD
Hydralazine—Dermatitis—Temozolomide—malignant glioma	0.00116	0.00663	CcSEcCtD
Hydralazine—Headache—Temozolomide—malignant glioma	0.00115	0.0066	CcSEcCtD
Hydralazine—Nausea—Carmustine—malignant glioma	0.00113	0.00647	CcSEcCtD
Hydralazine—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00111	0.0138	CbGpPWpGaD
Hydralazine—Nausea—Temozolomide—malignant glioma	0.00109	0.00626	CcSEcCtD
Hydralazine—RYR2—Ion channel transport—RAF1—malignant glioma	0.00106	0.0132	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00102	0.0128	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—malignant glioma	0.000985	0.0123	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.00098	0.0122	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000978	0.0122	CbGpPWpGaD
Hydralazine—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000959	0.012	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000928	0.0116	CbGpPWpGaD
Hydralazine—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000898	0.0112	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000853	0.0106	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00083	0.0104	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000812	0.0101	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000797	0.00995	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000759	0.00948	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000723	0.00903	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000711	0.00888	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000492	0.00615	CbGpPWpGaD
Hydralazine—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000488	0.00609	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000459	0.00573	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000453	0.00566	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000398	0.00497	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000393	0.0049	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000372	0.00465	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000368	0.00459	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000323	0.00403	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000269	0.00335	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000245	0.00305	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000231	0.00289	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000198	0.00247	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000195	0.00243	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000171	0.00214	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000169	0.00211	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000148	0.00185	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000139	0.00173	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.00013	0.00162	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—RTEL1—malignant glioma	9.72e-05	0.00121	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	9.61e-05	0.0012	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	9.48e-05	0.00118	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—COX8A—malignant glioma	5.58e-05	0.000697	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ASMT—malignant glioma	4.74e-05	0.000592	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BCAN—malignant glioma	4.46e-05	0.000557	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—IDH2—malignant glioma	3.6e-05	0.000449	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.38e-05	0.000422	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—IDH1—malignant glioma	3.09e-05	0.000386	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SPHK1—malignant glioma	2.99e-05	0.000374	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.93e-05	0.000366	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTT1—malignant glioma	2.37e-05	0.000296	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS1—malignant glioma	2.22e-05	0.000277	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BCHE—malignant glioma	2.07e-05	0.000258	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.04e-05	0.000255	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTP1—malignant glioma	1.64e-05	0.000205	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAT—malignant glioma	1.6e-05	0.0002	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.51e-05	0.000189	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAV1—malignant glioma	1.23e-05	0.000154	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.12e-05	0.00014	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARG—malignant glioma	1.08e-05	0.000135	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.86e-06	0.000123	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.59e-06	0.000107	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—malignant glioma	8.51e-06	0.000106	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTEN—malignant glioma	7.42e-06	9.27e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.24e-06	6.54e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKT1—malignant glioma	4.28e-06	5.34e-05	CbGpPWpGaD
